|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000153531 |
Summary for ADPRHL1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000153531 | Gene symbol | ADPRHL1 |
| Gene name | ADP-ribosylhydrolase like 1 | |
| HGNC | 21303 | |
| Entrez ID | 113622 | |
| Gene type | protein_coding | |
| Synonyms | ADPRHL1|ARH2 | |
| UniProtAcc | Q8NDY3 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ADPRHL1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ADPRHL1 | 1.22e+02 | -1.29e+00 | 3.38e-01 | -3.80e+00 | 1.42e-04 | 9.91e-03 | ACC |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for ADPRHL1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ADPRHL1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| CHOL | cg20773767 | chr13:113453616 | CGI:chr13:113441735-113442002 | promoter | 6.34e-01 | 5.33e-01 | 2.61e+00 | 9.04e-03 | 2.00e-02 | 1.01e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| THCA | cg21243846 | chr13:113453690 | CGI:chr13:113441735-113442002 | promoter | 7.59e-01 | 6.45e-01 | 3.80e+00 | 1.47e-04 | 7.83e-04 | 1.14e-01 |
| LUSC | cg12622519 | chr13:113453737 | CGI:chr13:113441735-113442002 | promoter | 7.12e-01 | 8.63e-01 | -2.93e+00 | 3.39e-03 | 6.12e-03 | -1.51e-01 |
| LUSC | cg14845091 | chr13:113453641 | CGI:chr13:113441735-113442002 | promoter | 6.59e-01 | 7.67e-01 | -2.57e+00 | 1.03e-02 | 1.41e-02 | -1.08e-01 |
| LUSC | cg21243846 | chr13:113453690 | CGI:chr13:113441735-113442002 | promoter | 5.84e-01 | 7.27e-01 | -3.08e+00 | 2.10e-03 | 4.33e-03 | -1.43e-01 |
| LUSC | cg23417523 | chr13:113453697 | CGI:chr13:113441735-113442002 | promoter | 7.24e-01 | 8.48e-01 | -3.05e+00 | 2.27e-03 | 4.57e-03 | -1.24e-01 |
| LUSC | cg21304833 | chr13:113453713 | CGI:chr13:113441735-113442002 | promoter | 6.79e-01 | 8.20e-01 | -2.91e+00 | 3.60e-03 | 6.40e-03 | -1.41e-01 |
| COAD | cg12622519 | chr13:113453737 | CGI:chr13:113441735-113442002 | promoter | 8.25e-01 | 7.03e-01 | 4.07e+00 | 4.73e-05 | 1.94e-04 | 1.21e-01 |
| COAD | cg21243846 | chr13:113453690 | CGI:chr13:113441735-113442002 | promoter | 7.54e-01 | 6.53e-01 | 3.77e+00 | 1.62e-04 | 5.14e-04 | 1.01e-01 |
| COAD | cg21304833 | chr13:113453713 | CGI:chr13:113441735-113442002 | promoter | 7.92e-01 | 6.87e-01 | 3.91e+00 | 9.40e-05 | 3.34e-04 | 1.06e-01 |
| BLCA | cg12622519 | chr13:113453737 | CGI:chr13:113441735-113442002 | promoter | 7.50e-01 | 5.81e-01 | 3.91e+00 | 9.24e-05 | 3.78e-04 | 1.69e-01 |
| BLCA | cg27490101 | chr13:113453475 | CGI:chr13:113441735-113442002 | UTR,promoter,exon,gene body | 9.33e-01 | 8.05e-01 | 4.61e+00 | 3.95e-06 | 6.73e-05 | 1.27e-01 |
| BLCA | cg01679512 | chr13:113454337 | CGI:chr13:113441735-113442002 | promoter | 9.19e-01 | 7.80e-01 | 4.36e+00 | 1.32e-05 | 1.10e-04 | 1.39e-01 |
| BLCA | cg00463202 | chr13:113453395 | CGI:chr13:113441735-113442002 | promoter,exon,CDS,gene body | 8.28e-01 | 6.70e-01 | 4.39e+00 | 1.13e-05 | 1.02e-04 | 1.58e-01 |
| BLCA | cg20731693 | chr13:113453561 | CGI:chr13:113441735-113442002 | promoter | 8.64e-01 | 6.97e-01 | 4.54e+00 | 5.64e-06 | 7.53e-05 | 1.66e-01 |
| BLCA | cg14845091 | chr13:113453641 | CGI:chr13:113441735-113442002 | promoter | 6.87e-01 | 5.83e-01 | 3.44e+00 | 5.73e-04 | 1.47e-03 | 1.03e-01 |
| BLCA | cg21243846 | chr13:113453690 | CGI:chr13:113441735-113442002 | promoter | 6.31e-01 | 5.26e-01 | 2.90e+00 | 3.73e-03 | 6.44e-03 | 1.05e-01 |
| BLCA | cg23417523 | chr13:113453697 | CGI:chr13:113441735-113442002 | promoter | 7.61e-01 | 6.33e-01 | 3.73e+00 | 1.91e-04 | 6.40e-04 | 1.28e-01 |
| BLCA | cg21304833 | chr13:113453713 | CGI:chr13:113441735-113442002 | promoter | 7.24e-01 | 5.58e-01 | 4.05e+00 | 5.18e-05 | 2.53e-04 | 1.67e-01 |
| BLCA | cg21834032 | chr13:113454118 | CGI:chr13:113441735-113442002 | promoter | 8.91e-01 | 7.53e-01 | 4.46e+00 | 8.01e-06 | 8.63e-05 | 1.37e-01 |
| KIRP | cg12622519 | chr13:113453737 | CGI:chr13:113441735-113442002 | promoter | 9.32e-01 | 8.26e-01 | 6.16e+00 | 7.44e-10 | 5.01e-08 | 1.07e-01 |
| KIRP | cg14845091 | chr13:113453641 | CGI:chr13:113441735-113442002 | promoter | 8.50e-01 | 7.36e-01 | 5.86e+00 | 4.72e-09 | 9.33e-08 | 1.14e-01 |
| ESCA | cg23359401 | chr13:113452330 | CGI:chr13:113441735-113442002 | promoter,gene body | 8.47e-01 | 5.83e-01 | 3.30e+00 | 9.81e-04 | 3.37e-02 | 2.65e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg12622519 | chr13:113453737 | CGI:chr13:113441735-113442002 | promoter | 8.55e-01 | 7.48e-01 | 1.15e+01 | 9.95e-31 | 1.59e-29 | 1.08e-01 |
| BRCA | cg20773767 | chr13:113453616 | CGI:chr13:113441735-113442002 | promoter | 5.56e-01 | 4.08e-01 | 1.18e+01 | 2.55e-32 | 5.00e-31 | 1.47e-01 |
| BRCA | cg21243846 | chr13:113453690 | CGI:chr13:113441735-113442002 | promoter | 7.34e-01 | 5.93e-01 | 1.26e+01 | 1.17e-36 | 4.57e-35 | 1.40e-01 |
| BRCA | cg21304833 | chr13:113453713 | CGI:chr13:113441735-113442002 | promoter | 8.01e-01 | 6.50e-01 | 1.35e+01 | 1.52e-41 | 1.77e-39 | 1.51e-01 |
| HNSC | cg12622519 | chr13:113453737 | CGI:chr13:113441735-113442002 | promoter | 7.60e-01 | 6.14e-01 | 3.12e+00 | 1.80e-03 | 9.59e-03 | 1.46e-01 |
| HNSC | cg14339867 | chr13:113453239 | CGI:chr13:113441735-113442002 | promoter,exon,CDS,gene body | 9.40e-01 | 7.93e-01 | 3.07e+00 | 2.18e-03 | 9.99e-03 | 1.47e-01 |
| HNSC | cg20773767 | chr13:113453616 | CGI:chr13:113441735-113442002 | promoter | 4.84e-01 | 3.55e-01 | 2.93e+00 | 3.40e-03 | 1.14e-02 | 1.30e-01 |
| HNSC | cg14845091 | chr13:113453641 | CGI:chr13:113441735-113442002 | promoter | 7.14e-01 | 5.85e-01 | 3.13e+00 | 1.73e-03 | 9.52e-03 | 1.28e-01 |
| HNSC | cg23417523 | chr13:113453697 | CGI:chr13:113441735-113442002 | promoter | 7.67e-01 | 6.11e-01 | 3.23e+00 | 1.22e-03 | 9.09e-03 | 1.55e-01 |
Top |
Exon skipping events with PSI in TCGA for ADPRHL1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ADPRHL1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ADPRHL1 |
| TFs related to ADPRHL1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | ZNF287 | ADPRHL1 | 4.45e+00 | 9.90e-01 | 2.59e+00 | 1.49e-03 | Male-biased |
| BRCA | ZNF487 | ADPRHL1 | 4.32e+00 | 9.88e-01 | 2.57e+00 | 2.06e-03 | Male-biased |
| CHOL | ZNF571 | ADPRHL1 | 3.90e+00 | 9.80e-01 | 2.81e+00 | 5.84e-03 | Male-biased |
| LGG | MAX | ADPRHL1 | 3.47e+00 | 3.46e-03 | 4.16e+00 | 9.83e-01 | Female-biased |
| LGG | MYCN | ADPRHL1 | 3.11e+00 | 1.19e-03 | 4.01e+00 | 9.80e-01 | Female-biased |
| LGG | NPAS2 | ADPRHL1 | 3.59e+00 | 3.05e-03 | 4.30e+00 | 9.86e-01 | Female-biased |
| LGG | ZNF777 | ADPRHL1 | 3.92e+00 | 4.79e-03 | 4.55e+00 | 9.88e-01 | Female-biased |
| PAAD | ZNF181 | ADPRHL1 | 3.34e+00 | 8.29e-03 | 4.18e+00 | 9.82e-01 | Female-biased |
| PAAD | ZNF443 | ADPRHL1 | 3.36e+00 | 5.97e-03 | 4.27e+00 | 9.85e-01 | Female-biased |
| PAAD | ZNF571 | ADPRHL1 | 3.35e+00 | 8.32e-03 | 4.19e+00 | 9.82e-01 | Female-biased |
| PCPG | ESR2 | ADPRHL1 | 2.91e+00 | 1.67e-03 | 4.10e+00 | 9.87e-01 | Female-biased |
| PCPG | FOXA2 | ADPRHL1 | 4.06e+00 | 9.85e-01 | 2.74e+00 | 8.49e-04 | Male-biased |
| PCPG | NKX2-2 | ADPRHL1 | 4.48e+00 | 9.91e-01 | 3.20e+00 | 1.09e-03 | Male-biased |
| PCPG | NR2E1 | ADPRHL1 | 4.02e+00 | 9.80e-01 | 3.06e+00 | 4.59e-03 | Male-biased |
| PCPG | SOX2 | ADPRHL1 | 4.44e+00 | 9.91e-01 | 3.22e+00 | 1.46e-03 | Male-biased |
| PCPG | SOX21 | ADPRHL1 | 4.53e+00 | 9.91e-01 | 3.32e+00 | 1.60e-03 | Male-biased |
| PCPG | SOX4 | ADPRHL1 | 4.24e+00 | 9.88e-01 | 2.98e+00 | 1.15e-03 | Male-biased |
| PCPG | SOX7 | ADPRHL1 | 4.35e+00 | 9.90e-01 | 3.04e+00 | 9.28e-04 | Male-biased |
| PCPG | SRY | ADPRHL1 | 4.77e+00 | 9.94e-01 | 3.45e+00 | 8.98e-04 | Male-biased |
| PCPG | ZIC3 | ADPRHL1 | 2.77e+00 | 2.09e-03 | 3.91e+00 | 9.82e-01 | Female-biased |
| PCPG | ZIC5 | ADPRHL1 | 2.94e+00 | 3.36e-03 | 3.97e+00 | 9.82e-01 | Female-biased |
| PCPG | ZNF101 | ADPRHL1 | 2.54e+00 | 3.94e-04 | 4.03e+00 | 9.87e-01 | Female-biased |
| PCPG | ZNF16 | ADPRHL1 | 2.52e+00 | 6.84e-04 | 3.89e+00 | 9.83e-01 | Female-biased |
| PCPG | ZNF419 | ADPRHL1 | 2.65e+00 | 1.53e-03 | 3.85e+00 | 9.81e-01 | Female-biased |
| PCPG | ZNF506 | ADPRHL1 | 2.34e+00 | 2.83e-04 | 3.88e+00 | 9.83e-01 | Female-biased |
| PCPG | ZNF605 | ADPRHL1 | 2.60e+00 | 1.22e-03 | 3.86e+00 | 9.81e-01 | Female-biased |
| ADPRHL1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ADPRHL1 |
| RBPs related to ES in ADPRHL1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ADPRHL1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs16968240 | chr13:106132940:T:G | - | 0.137298526034062 | 0.00324441567645641 | HNSC | Female-baised eQTL |
| rs12853766 | chr13:106131260:C:T | - | 0.131157703527769 | 0.00601654088022197 | HNSC | Female-baised eQTL |
| rs35484904 | chr13:106136508:T:C | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs34809681 | chr13:106136584:T:C | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs77320877 | chr13:106137068:C:G | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs78683884 | chr13:106138648:T:A | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs34271456 | chr13:106139016:G:T | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs35241941 | chr13:106139850:A:G | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs12866099 | chr13:106141125:C:T | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs17182032 | chr13:106145181:A:G | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs17182039 | chr13:106145270:T:G | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs77875420 | chr13:106145547:C:G | - | 0.126522971151122 | 0.0086391639048575 | HNSC | Female-baised eQTL |
| rs71432884 | chr13:106141851:A:T | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs74318301 | chr13:106142382:C:G | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs71432885 | chr13:106142701:C:T | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs12430354 | chr13:106143147:G:T | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs12431372 | chr13:106143544:T:C | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs34721592 | chr13:106144405:G:C | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs75425260 | chr13:106146586:A:G | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs75682630 | chr13:106146588:T:C | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs36078907 | chr13:106149658:C:A | - | 0.126257532701826 | 0.00887935066916039 | HNSC | Female-baised eQTL |
| rs12428508 | chr13:106147252:T:C | - | 0.119653476856376 | 0.0180942861723768 | HNSC | Female-baised eQTL |
| rs12429472 | chr13:106147383:A:G | - | 0.119653476856376 | 0.0180942861723768 | HNSC | Female-baised eQTL |
| rs71432886 | chr13:106147647:G:A | - | 0.119653476856376 | 0.0180942861723768 | HNSC | Female-baised eQTL |
| rs7986950 | chr13:106156466:C:G | - | 0.126683849269958 | 0.0227811350366509 | HNSC | Female-baised eQTL |
| rs34398902 | chr13:106151265:C:T | - | 0.122230849768217 | 0.028118369969214 | HNSC | Female-baised eQTL |
| rs11842938 | chr13:106135733:T:C | - | 0.113528730559629 | 0.0318335399554978 | HNSC | Female-baised eQTL |
| rs34285600 | chr13:106157310:T:A | - | 0.120342934197524 | 0.0363748393987483 | HNSC | Female-baised eQTL |
| rs12874565 | chr13:106158005:T:C | - | 0.12033475243966 | 0.036653770990383 | HNSC | Female-baised eQTL |
| rs7986944 | chr13:106156464:C:T | - | 0.115286222015203 | 0.0495044183589766 | HNSC | Female-baised eQTL |
| rs55935772 | chr13:109193279:A:G | - | 0.0862304645647526 | 0.032120573649633 | SARC | Female-baised eQTL |
| rs74123524 | chr13:109186107:A:G | - | 0.0846679149761091 | 0.0408541161625661 | SARC | Female-baised eQTL |
| rs74123526 | chr13:109186979:T:C | - | 0.0846679149761091 | 0.0408541161625661 | SARC | Female-baised eQTL |
| rs74123528 | chr13:109190409:T:C | - | 0.0846679149761091 | 0.0408541161625661 | SARC | Female-baised eQTL |
| rs73562172 | chr13:105094083:C:G | - | 0.154611157731753 | 0.00171072534394437 | STAD | Female-baised eQTL |
| rs112942910 | chr13:105092393:C:T | - | 0.154239202161796 | 0.00179322076902913 | STAD | Female-baised eQTL |
| rs73562156 | chr13:105089288:G:A | - | 0.148601426877145 | 0.00227455144023316 | STAD | Female-baised eQTL |
| rs73562160 | chr13:105090247:T:C | - | 0.148601426877145 | 0.00227455144023316 | STAD | Female-baised eQTL |
| rs73562164 | chr13:105092074:G:A | - | 0.148601426877145 | 0.00227455144023316 | STAD | Female-baised eQTL |
| rs73562141 | chr13:105081977:T:C | - | 0.136272268093035 | 0.00501513045644594 | STAD | Female-baised eQTL |
| rs74111153 | chr13:105078343:A:G | - | 0.124709250739932 | 0.00603323753387386 | STAD | Female-baised eQTL |
| rs7323919 | chr13:105075299:C:T | - | 0.112048067180702 | 0.0449257035034535 | STAD | Female-baised eQTL |
| rs7323731 | chr13:105075197:C:T | - | 0.111290105879253 | 0.0487039706138408 | STAD | Female-baised eQTL |
| rs9300992 | chr13:105076140:C:T | - | 0.111290105879253 | 0.0487039706138408 | STAD | Female-baised eQTL |
| rs17373318 | chr13:104290856:T:C | - | 0.167034178829901 | 0.00315579847673107 | BLCA | Female-baised eQTL |
| rs9586467 | chr13:104314052:A:G | - | 0.139362729444365 | 0.0252244406704427 | BLCA | Female-baised eQTL |
| rs9586465 | chr13:104308514:T:G | - | 0.138936647811873 | 0.0263065999003659 | BLCA | Female-baised eQTL |
| rs16964534 | chr13:104296223:G:A | - | 0.13924675214084 | 0.0273692822331762 | BLCA | Female-baised eQTL |
| rs9989129 | chr13:104298050:C:T | - | 0.13924675214084 | 0.0273692822331762 | BLCA | Female-baised eQTL |
| rs10508138 | chr13:104299231:G:A | - | 0.13924675214084 | 0.0273692822331762 | BLCA | Female-baised eQTL |
| rs80115225 | chr13:107047984:G:T | - | 0.17260389707443 | 0.0427935665314834 | BLCA | Female-baised eQTL |
| rs17381165 | chr13:108345490:C:A | - | 0.0591417775431945 | 0.0160890326443812 | LUAD | Female-baised eQTL |
| rs355348 | chr13:106171872:A:G | - | -0.0686330090591709 | 0.0254190877247452 | LUAD | Female-baised eQTL |
| rs355339 | chr13:106162884:C:T | - | -0.0650990840244145 | 0.043718793442352 | LUAD | Female-baised eQTL |
| rs61972049 | chr13:108408205:A:G | - | 0.0536578792647515 | 0.0454680452887369 | LUAD | Female-baised eQTL |
| rs12865938 | chr13:108112059:A:C | - | 0.0787444700351121 | 0.02881464517044 | COAD | Female-baised eQTL |
| rs34642561 | chr13:108113671:A:G | - | 0.0787444700351121 | 0.02881464517044 | COAD | Female-baised eQTL |
| rs11616923 | chr13:108113748:C:A | - | 0.0779915771679026 | 0.0322449967284984 | COAD | Female-baised eQTL |
| rs11839296 | chr13:108104570:T:A | - | 0.0771103934022451 | 0.0345111000152042 | COAD | Female-baised eQTL |
| rs76447240 | chr13:108107504:T:C | - | 0.0771103934022451 | 0.0345111000152042 | COAD | Female-baised eQTL |
| rs12429506 | chr13:108111541:A:G | - | 0.0753358260887368 | 0.0433711389446083 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12427557 | chr13:103716917:A:G | - | 0.0465688662670807 | 0.0130570661031395 | HNSC | Male-baised eQTL |
| rs34195009 | chr13:103712306:A:C | - | 0.0437996539881336 | 0.0266280560633332 | HNSC | Male-baised eQTL |
| rs61970046 | chr13:103713308:T:C | - | 0.0437996539881336 | 0.0266280560633332 | HNSC | Male-baised eQTL |
| rs9519143 | chr13:103718399:T:C | - | -0.0417797430379448 | 0.0370994357563296 | HNSC | Male-baised eQTL |
| rs6491789 | chr13:103718101:A:T | - | -0.0415470135395278 | 0.0389316012814751 | HNSC | Male-baised eQTL |
| rs6491790 | chr13:103718213:T:C | - | -0.0415470135395278 | 0.0389316012814751 | HNSC | Male-baised eQTL |
| rs6491791 | chr13:103718214:G:A | - | -0.0415470135395278 | 0.0389316012814751 | HNSC | Male-baised eQTL |
| rs1854887 | chr13:103715049:C:T | - | -0.0416596472382481 | 0.0413447887411 | HNSC | Male-baised eQTL |
| rs7324233 | chr13:103718392:C:T | - | -0.0413615805015945 | 0.0420974551044223 | HNSC | Male-baised eQTL |
| rs61969403 | chr13:109209707:C:T | - | 0.0693651859197527 | 0.0442974015421341 | HNSC | Male-baised eQTL |
| rs4426222 | chr13:108648410:C:G | - | 0.186440381588439 | 0.00164076100738026 | SARC | Male-baised eQTL |
| rs9583274 | chr13:108651207:G:A | - | 0.186440381588439 | 0.00164076100738026 | SARC | Male-baised eQTL |
| rs4438160 | chr13:108108467:T:G | - | -0.188949290200098 | 0.00312068758275062 | SARC | Male-baised eQTL |
| rs1931352 | chr13:108117599:C:T | - | -0.188949290200098 | 0.00312068758275062 | SARC | Male-baised eQTL |
| rs1969890 | chr13:110549943:T:C | - | -0.139667987614801 | 0.00358360219584355 | SARC | Male-baised eQTL |
| rs9603947 | chr13:112782114:T:G | - | 0.190857955942248 | 0.00939272740895978 | SARC | Male-baised eQTL |
| rs16971838 | chr13:108083199:G:T | - | 0.169986916734714 | 0.0104562326258729 | SARC | Male-baised eQTL |
| rs9559243 | chr13:108083460:A:G | - | 0.169986916734714 | 0.0104562326258729 | SARC | Male-baised eQTL |
| rs1408908 | chr13:108086432:G:T | - | 0.169986916734714 | 0.0104562326258729 | SARC | Male-baised eQTL |
| rs16971867 | chr13:108092963:T:C | - | 0.169986916734714 | 0.0104562326258729 | SARC | Male-baised eQTL |
| rs9559245 | chr13:108093828:C:T | - | 0.169986916734714 | 0.0104562326258729 | SARC | Male-baised eQTL |
| rs9559248 | chr13:108098943:A:G | - | 0.169986916734714 | 0.0104562326258729 | SARC | Male-baised eQTL |
| rs74969993 | chr13:108102470:T:C | - | 0.169986916734714 | 0.0104562326258729 | SARC | Male-baised eQTL |
| rs7327665 | chr13:112600296:C:G | - | 0.112060060942004 | 0.0160770742490866 | SARC | Male-baised eQTL |
| rs912941 | chr13:110550925:T:C | - | -0.109801791959283 | 0.034045137399174 | SARC | Male-baised eQTL |
| rs1886871 | chr13:110551070:C:T | - | -0.109801791959283 | 0.034045137399174 | SARC | Male-baised eQTL |
| rs73558820 | chr13:105099561:G:A | - | 0.0673522589474333 | 0.0438666208918273 | LIHC | Male-baised eQTL |
| rs3015388 | chr13:105164239:A:G | - | 0.0753270773422349 | 2.04791859270382e-05 | LUAD | Male-baised eQTL |
| rs3015389 | chr13:105167980:T:A | - | 0.0753270773422349 | 2.04791859270382e-05 | LUAD | Male-baised eQTL |
| rs3015399 | chr13:105191283:A:G | - | 0.0750640327238748 | 2.95921334212359e-05 | LUAD | Male-baised eQTL |
| rs3015400 | chr13:105191497:G:T | - | 0.0750640327238748 | 2.95921334212359e-05 | LUAD | Male-baised eQTL |
| rs3015411 | chr13:105196972:A:G | - | 0.0750640327238748 | 2.95921334212359e-05 | LUAD | Male-baised eQTL |
| rs3015412 | chr13:105197870:T:G | - | 0.0750640327238748 | 2.95921334212359e-05 | LUAD | Male-baised eQTL |
| rs3015414 | chr13:105198693:C:T | - | 0.0750640327238748 | 2.95921334212359e-05 | LUAD | Male-baised eQTL |
| rs3015343 | chr13:105205723:G:A | - | 0.0750640327238748 | 2.95921334212359e-05 | LUAD | Male-baised eQTL |
| rs3015407 | chr13:105195194:C:G | - | 0.0693356758328642 | 8.65371296894393e-05 | LUAD | Male-baised eQTL |
| rs4772555 | chr13:103455107:T:C | - | 0.0686323623372118 | 0.000126419674707909 | LUAD | Male-baised eQTL |
| rs3007246 | chr13:105169695:C:T | - | 0.0653426622982435 | 0.000215778815055271 | LUAD | Male-baised eQTL |
| rs3015406 | chr13:105194978:A:G | - | 0.0662931871606605 | 0.000217633007188807 | LUAD | Male-baised eQTL |
| rs3015396 | chr13:105186771:C:T | - | 0.0612811206906163 | 0.000791786518109561 | LUAD | Male-baised eQTL |
| rs3007244 | chr13:105138711:C:T | - | 0.0588709667548967 | 0.000958183110920525 | LUAD | Male-baised eQTL |
| rs11620318 | chr13:108946303:T:G | - | 0.0604978307821499 | 0.000982470148222445 | LUAD | Male-baised eQTL |
| rs74879687 | chr13:104759667:A:C | - | 0.0551753861399595 | 0.00195581840713651 | LUAD | Male-baised eQTL |
| rs3007256 | chr13:105186709:T:A | - | 0.0555247881867887 | 0.00225667415793478 | LUAD | Male-baised eQTL |
| rs3015410 | chr13:105195940:C:T | - | 0.0535353675537872 | 0.00228208549152341 | LUAD | Male-baised eQTL |
| rs3007276 | chr13:105143843:A:G | - | 0.0549516324912795 | 0.00238696511195563 | LUAD | Male-baised eQTL |
| rs3007252 | chr13:105140729:C:T | - | 0.052532361236684 | 0.00327754280826602 | LUAD | Male-baised eQTL |
| rs11069586 | chr13:105132919:C:G | - | -0.0517318623023698 | 0.00441538344585355 | LUAD | Male-baised eQTL |
| rs9604351 | chr13:112544137:C:T | - | 0.0504496044705413 | 0.00501594875545639 | LUAD | Male-baised eQTL |
| rs3007251 | chr13:105140644:C:T | - | 0.0476163982055223 | 0.00951680286973425 | LUAD | Male-baised eQTL |
| rs3015372 | chr13:105142243:G:A | - | 0.0476329428512682 | 0.00954200654575041 | LUAD | Male-baised eQTL |
| rs3015369 | chr13:105140959:G:C | - | 0.0466715487787854 | 0.011202749819264 | LUAD | Male-baised eQTL |
| rs3015371 | chr13:105142057:T:C | - | 0.0466715487787854 | 0.011202749819264 | LUAD | Male-baised eQTL |
| rs3007259 | chr13:105142252:T:A | - | 0.0466715487787854 | 0.011202749819264 | LUAD | Male-baised eQTL |
| rs3007261 | chr13:105142604:A:T | - | 0.0466715487787854 | 0.011202749819264 | LUAD | Male-baised eQTL |
| rs3007263 | chr13:105142873:C:T | - | 0.0466715487787854 | 0.011202749819264 | LUAD | Male-baised eQTL |
| rs9555666 | chr13:110073751:C:T | - | 0.0463153282980367 | 0.0114685054075796 | LUAD | Male-baised eQTL |
| rs9559724 | chr13:110077745:C:T | - | 0.0461622162391271 | 0.0119532056652058 | LUAD | Male-baised eQTL |
| rs9559723 | chr13:110077703:G:C | - | 0.0445225410755371 | 0.0124631626422666 | LUAD | Male-baised eQTL |
| rs9559725 | chr13:110084434:G:T | - | 0.0454992622525465 | 0.012974705690273 | LUAD | Male-baised eQTL |
| rs1373746 | chr13:110088429:A:G | - | 0.0454762365761357 | 0.0130150073511306 | LUAD | Male-baised eQTL |
| rs1824721 | chr13:106383825:C:G | - | 0.0474964796948666 | 0.0144363906320667 | LUAD | Male-baised eQTL |
| rs9559722 | chr13:110072718:G:T | - | 0.0451016339523628 | 0.0147259704357157 | LUAD | Male-baised eQTL |
| rs9583541 | chr13:110863561:C:T | - | 0.0426654360035639 | 0.0184113768889832 | LUAD | Male-baised eQTL |
| rs7334606 | chr13:110864283:T:C | - | 0.0426569727035077 | 0.0185241597077266 | LUAD | Male-baised eQTL |
| rs3015370 | chr13:105141419:G:A | - | 0.0434524576555101 | 0.0192790860164007 | LUAD | Male-baised eQTL |
| rs9604340 | chr13:112536718:A:G | - | 0.0419745985461335 | 0.0252184125460042 | LUAD | Male-baised eQTL |
| rs9604342 | chr13:112537463:T:C | - | 0.0419745985461335 | 0.0252184125460042 | LUAD | Male-baised eQTL |
| rs17121253 | chr13:112546146:C:T | - | 0.0419600645266007 | 0.0253303976461222 | LUAD | Male-baised eQTL |
| rs9559721 | chr13:110070644:G:A | - | 0.0411479658201101 | 0.0290486226775531 | LUAD | Male-baised eQTL |
| rs11618575 | chr13:106163239:A:G | - | 0.0406036567802 | 0.0295006084580474 | LUAD | Male-baised eQTL |
| rs17792320 | chr13:106163721:C:A | - | 0.0406036567802 | 0.0295006084580474 | LUAD | Male-baised eQTL |
| rs12583090 | chr13:106168364:G:A | - | 0.04061185310429 | 0.0295457223024854 | LUAD | Male-baised eQTL |
| rs9559728 | chr13:110092942:C:T | - | 0.0407435837327955 | 0.0296178713987611 | LUAD | Male-baised eQTL |
| rs9559729 | chr13:110095074:A:G | - | 0.0407435837327955 | 0.0296178713987611 | LUAD | Male-baised eQTL |
| rs6492320 | chr13:110865356:A:G | - | 0.0395870596260005 | 0.0297802325357707 | LUAD | Male-baised eQTL |
| rs9559720 | chr13:110067636:C:T | - | 0.0392965986217303 | 0.0323293452512493 | LUAD | Male-baised eQTL |
| rs9555665 | chr13:110068832:G:T | - | 0.0385495200712183 | 0.0373241698490633 | LUAD | Male-baised eQTL |
| rs41288616 | chr13:112547505:C:T | - | 0.0393684401095307 | 0.0382410091659383 | LUAD | Male-baised eQTL |
| rs9604358 | chr13:112552424:G:A | - | 0.0391188641320837 | 0.0405145531009976 | LUAD | Male-baised eQTL |
| rs9559718 | chr13:110066116:T:C | - | 0.037575411385806 | 0.0428352652553758 | LUAD | Male-baised eQTL |
| rs9324310 | chr13:112557004:T:G | - | 0.0383242760213844 | 0.0469126939399343 | LUAD | Male-baised eQTL |
| rs55794546 | chr13:112572122:G:A | - | 0.0383242760213844 | 0.0469126939399343 | LUAD | Male-baised eQTL |
| rs11841561 | chr13:104704584:T:C | - | 0.108992052963944 | 0.00609240504448092 | COAD | Male-baised eQTL |
| rs7139896 | chr13:104699648:C:T | - | 0.10077520974347 | 0.015241203769202 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000153531 |
| CpG Site: cg03242905 | |
| Position to Gene: gene | |
| Male Effect: -0.49206616697757 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg03242905 | chr13:113426761 | gene | -0.49206616697757 | 1.29218968617969e-162 | -0.9845986401363647 | 2.259650592981657e-169 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ADPRHL1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
